Cuba exposure profile · BMY ·
Health Care
Bristol Myers Squibb (BMY): Cuba Exposure Check
Independent audit of Bristol Myers Squibb's exposure to Cuba — OFAC SDN matches, Helms-Burton Title III risk, SEC filings, and the Cuban Insights news corpus.
OFAC Cuba SDN matches
No entry on the OFAC Cuba SDN list contains
Bristol Myers Squibb
as of the most recent OFAC scrape. Always re-verify with
OFAC Sanctions Search
before transacting.
SEC filings disclosing Cuba items
Bristol Myers Squibb has filed 1 recent SEC document containing references to Cuba, the CACR, Helms-Burton, GAESA, or related terms. These are the company's own disclosures.
Federal Register & news corpus mentions
No Federal Register notice or analyzed news article in our
corpus references Bristol Myers Squibb in a
Cuba context. Search the live
sanctions tracker
or the
daily briefing index
for ad-hoc context.
Methodology.
This page combines four signals: (1) a hand-curated map of S&P 500
Cuba exposure maintained by Cuban Insights analysts;
(2) fuzzy substring matching against every Cuba-program OFAC SDN
designation and the State Department Cuba Restricted List (refreshed
twice daily); (3) the SEC EDGAR full-text search across the company's
10-K, 10-Q, 8-K, 20-F, and 6-K filings for the past 24 months — including
Helms-Burton Title III trafficking-claim disclosures; (4) a scan of our
own analyzed-news corpus and US Federal Register notices. Last refreshed
2026-07-21. This is not legal or compliance advice;
always verify with primary sources and qualified sanctions counsel
before transacting.
Frequently asked questions
Is Bristol Myers Squibb (BMY) sanctioned by OFAC?
As of July 2026, Bristol Myers Squibb (BMY) is not listed on the OFAC CUBA-program SDN list. No direct or subsidiary entity match was found in our scan against the live US Treasury SDN feed. Note that the State Department's Cuba Restricted List and Cuba Prohibited Accommodations List apply separately and should be checked alongside the SDN. Always re-verify against the official OFAC Sanctions Search before relying on this for a compliance decision.
Does Bristol Myers Squibb have Cuba revenue exposure?
Bristol Myers Squibb has disclosed Cuba-related items in 1 recent SEC filing. Bristol Myers Squibb has filed 1 recent SEC document (8-K) containing Cuba / CACR / ETECSA / ALIMPORT / Helms-Burton references. This is the company's own disclosure and is the strongest evidence of m
Has Bristol Myers Squibb disclosed Cuba in its SEC filings?
Bristol Myers Squibb has filed 1 recent SEC document containing Cuba-related references (searched across 10-K, 10-Q, 8-K, 20-F, and 6-K filings on EDGAR over the last 24 months — queries include 'Cuba', 'Helms-Burton', 'CACR', 'Cuba Restricted List', and 'Havana'). See the SEC filings section on the page for the matched excerpts and links to each filing.
Useful tools
- Look up another public company's Cuba exposure
- SEC EDGAR Cuba / Helms-Burton / impairment search — pre-canned full-text search across S&P 500 10-K and 20-F filings
- OFAC Cuba sanctions checker — fuzzy SDN search by name or ID
- OFAC Cuba general licenses lookup (CACR §515.560–.578)
- Browse all active OFAC Cuba SDN designations
- Best enterprise OFAC screening tools — SDN platforms reviewed for coverage and update frequency
- Plain-English explainer: OFAC Cuba sanctions